SavedAdd your journal

Journals / Medical Science and Discovery / 2016 / Cilt: 3 Sayı: 10

Thyrotoxicosis due to functioning metastatic follicular thyroid cancer

Thyrotoxicosis formation due to functioning metastatic follicular thyroid cancer

Sadiye Altun TUZCU
Faruk KİLİNC
Zafer PEKKOLAY
Hikmet SOYLU
Alpaslan Kemal TUZCU
Pages
339–41
Publication Date
2016-10-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report we present a case of thyrotoxicosis due to metastatic follicular thyroid cancer with a huge metastatic lesion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thyrotoxicosis is a common condition associated with excess circulating thyroid hormones.
📊
Key Findings & Data:Most of patients with functional thyroid cancer metastases have had normal thyroxine (T4) concentrations but high serum triiodothyronine (T3-thyrotoxicosis).
💡
Conclusion & Impact:In this case report we present a case of thyrotoxicosis due to metastatic follicular thyroid cancer with a huge metastatic lesion.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:metastatic follicular thyroid cancer · thyrotoxicosis

Abstract

Thyrotoxicosis is a common condition associated with excess circulating thyroid hormones. Rarely, thyrotoxicosis can be developing due to functioning metastatic thyroid carcinoma. Most of patients with functional thyroid cancer metastases have had normal thyroxine (T4) concentrations but high serum triiodothyronine (T3-thyrotoxicosis). Inappropriately supressed TSH levels with normal T4 levels may be helpful to suspect T3 thyrotoxicosis. In this case report we present a case of thyrotoxicosis due to metastatic follicular thyroid cancer with a huge metastatic lesion.

🔖

Cite This Article

TUZCU, S. A., KİLİNC, F., PEKKOLAY, Z., SOYLU, H., TUZCU, A. K. (2016). Thyrotoxicosis due to functioning metastatic follicular thyroid cancer. Medical Science and Discovery, Cilt: 3 Sayı: 10, 339–41. https://ajindex.com/articles/1003060

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Vaidya B, Pearce SH. Diagnosis and management of thyrotoxicosis. BMJ. 2014; 21:349:g 5128. Nakashima T, Inoue K, Shiro-ozu A, et al. Predominant T3 synthesis in the metastatic thyroid carcinoma in a patient with T3-toxicosis. Metabolismi 1981;30:327-330.
  2. Paul SJ, Sisson JC. Thyrotoxicosis caused by thyroid cancer. Endocrinol Metab Clin North Am. 1990;19:593-612.
  3. Russo D, Tumino S, Arturi F, et al. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab.1997; 82:735-738.
  4. Miyauchi A, Takamura Y, Ito Y, et al. 3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma. J Clin Endocrinol Metab 2008; 93:2239. Kasagi K, Takeuchi R, Miyamoto S, et al. Rapid Control of T3 Thyrotoxicosis in Patients with Metastatic Follicular Thyroid Cancer Treated Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases. Clin Endocrinol (Oxf) 1994; 40:429.